Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 283-041-9 | CAS number: 84539-53-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- April 6-21, 1987
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Relatively well reported study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 987
- Report date:
- 1987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Acetic acid, oxo-, sodium salt, reaction products with cresol and ethylenediamine, iron sodium salts
- EC Number:
- 283-041-9
- EC Name:
- Acetic acid, oxo-, sodium salt, reaction products with cresol and ethylenediamine, iron sodium salts
- Cas Number:
- 84539-53-7
- Molecular formula:
- non specified (UVCB substance)
- IUPAC Name:
- non specified (UVCB substance)
- Details on test material:
- - Name of test material (as cited in study report): Bolikel FE
- Physical state: brown/red crystalline powder
- Lot/batch No.: Batch No. 2
- Storage condition of test material: ambient temperature, under dry conditions
- Other: received on February 27, 1987 (4 x 375 g)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (U.K) Limited, Margate, Kent, England
- Age at study initiation: young adult rats, approximately 5 weeks old
- Weight at study initiation: (pre-fasted) males 110 - 117 g; females 97 - 110 g.
- Fasting period before study: approximately 18 hours before administration of test material
- Housing: 5 animals of the same sex (in type RCI cages with stainless steel grid floors)
- Diet (e.g. ad libitum): fed without restriction (Laboratory animal diet no. 1 from Labsure, Manea, Cambridgeshire, England)
- Water (e.g. ad libitum): free access to tap water
- Acclimation period: at least 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 (range 18 - 25)
- Humidity (%): 55 (range 40 - 70)
- Air changes (per hr): 15 complete air changes per hour, without re-circulation
- Photoperiod (hrs dark / hrs light): 12 hours of artificial light per day
IN-LIFE DATES: From: April 6, 1987 To: April 21, 1987
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 25% w/v formulation in distilled water (250 mg/mL)
- Justification for choice of vehicle: not indicated
MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg - Doses:
- Dose: 5000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days (terminated on Day 15)
- Frequency of observations and weighing: Three separate inspections were made during the first hour after administration and two further inspections during the remainder of Day 1. From Day 2 onwards, the animals were inspected twice daily. The type, time of onset and duration of reactions to treatment were recorded. The bodyweight of each animal was recorded on the day before dosing and on Days 1, 8 and 15. The test was terminated on Day 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, macroscopic pathology - Statistics:
- Not applicable
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One female rat died during the first overnight period. There were no other deaths.
- Clinical signs:
- other: Decreased motor activity, hunched posture, piloerection and urinogenital staining from purple urine were observed in all rats during the first five hours after dosing. Surviving rats were ungroomed on Day 2, but all had fully recovered by Day 3 and remain
- Gross pathology:
- Necropsy of the decedent revealed fur staining, abnormal gastro-intestinal contents and extensive cannibalisation. Necropsy of the surviving rats revealed red staining of the perineum or ventral surface of several animals and less frequent observations of altered gastro-intestinal contents or dark lungs.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Remarks:
- Migrated information
- Conclusions:
- The acute oral median lethal dose to rats of Bolikel FE was found to be greater than 5000 mg/kg bodyweight. According to OECD-GHS Bolikel FE is not classified.
- Executive summary:
The study was performed according to OECD Guideline 401 (Acute Oral Toxicity) and according to GLP standards.
The test material, Bolikel FE was evaluated in a limit test for its acute oral toxicity potential in rats when administered as a gavage dose at a level of 5000 mg/kg to a group of 5 males and 5 females. One female rat died during the first overnight period. Clinical signs of toxicity included decreased motor activity, hunched posture, pilo-erection and urinogenital staining from purple urine; recovery was complete on Day 3. Gross pathologic examination at termination revealed red staining of the perineum or ventral surface of several animals and less frequent observations of altered gastro-intestinal contents or dark lungs.
The acute oral median lethal dose to rats of Bolikel FE was found to be greater than 5000 mg/kg bodyweight. According to OECD-GHS Bolikel FE is not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.